Cytokines and the immunomodulatory function of the vagus nerve

British Journal of Anaesthesia

Volumn 102, Issue 4, 2009, Pages 453-462

  Johnston, G R ^a   Webster, N R ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Complications, infection; Immune response; Parasympathetic nervous system, vagus; Polypeptides, cytokines

Indexed keywords

3 (2,4 DIMETHOXYBENZYLIDENE)ANABASEINE; ACETYLCHOLINE; CYTOKINE; GHRELIN; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MUSCARINIC RECEPTOR; NICOTINE; NICOTINIC RECEPTOR; SEMAPIMOD; TUMOR NECROSIS FACTOR ALPHA;

CYTOKINE PRODUCTION; DRUG MECHANISM; DRUG TARGETING; EFFERENT NERVE; EPILEPSY; HEMORRHAGIC SHOCK; HUMAN; IMMUNOMODULATION; INFLAMMATION; ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REPERFUSION INJURY; REVIEW; SENSORY NERVE; SEPSIS; VAGUS NERVE STIMULATION;

EID: 62549134850     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aep037     Document Type: Review

References (89)

1. Abraham E, Anzueto A, Gutierrez G, et al. Double-blind randomized controlled trial of monoclonal antibody to tumour necrosis factor in treatment of septic shock. Lancet 1998; 351: 929-33
2. Abraham E, Bursten S, Shenkar R, et al. Phosphatidic acid signaling mediates lung cytokine expression and lung inflammatory injury after hemorrhage in mice. J Exp Med 1995; 181: 569-75
3. Abraham E, Jesmok G, Tuder R, Allbee J, Chang Y. Contribution of tumor necrosis factor-alpha to pulmonary cytokine expression and lung injury after hemorrhage and resuscitation. Crit Care Med 1995; 23: 1319-26
4. Abraham E, Laterre P, Garbino J, et al. Lenercept (p55 tumor necrosis factor receptor fusion protein) in severe sepsis and early septic shock: a randomized, double-blind, placebo-controlled, multicenter phase III trial with 1,342 patients. Crit Care Med 2001; 29: 503-10
5. Andersson J. The inflammatory reflex - introduction. J Intern Med 2005; 257: 112-25
6. Banks WA, Kastin AJ. Blood to brain transport of interleukin links the immune and central nervous systems. Life Sci 1991; 48: 117-21
7. Bauhofer A, Torossian A. Mechanical vagus nerve stimulation - a new adjunct in sepsis prophylaxis and treatment. Crit Care Med 2007; 35: 2868-9
8. Bernik TR, Friedman SG, Ochani M, et al. Cholinergic anti-inflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion. J Vasc Surg 2002; 36: 1231-6
9. Bernik TR, Friedman SG, Ochani M, et al. Pharmacological stimulation of the cholinergic anti-inflammatory pathway. J Exp Med 2002; 195: 781-8
10. Bianchi M, Bloom O, Raabe T, et al. Suppression of pro-inflammatory cytokines in monocytes by a tetravalent guanylhydrazone. J Exp Med 1996; 183: 927-36
11. Blackwell TS, Christman JW. Sepsis and cytokines: current status. Br J Anaesth 1996; 77: 110-77
12. Blalock JE. The immune system as a sixth sense. J Intern Med 2005; 257: 126-38
13. Borovikova LV, Lyudmila V, Ivanova S, et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 2000; 405: 458-62
14. Bown MJ, Nicholson ML, Bell PRF, Sayers RD. Cytokines and inflammatory pathways in the pathogenesis of multiple organ failure following abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 2001; 22: 485-95
15. Carlstedt F, Lind L, Lindahl B. Pro-inflammatory cytokines, measured in a mixed population on arrival in the emergency department, are related to mortality and severity of disease. J Intern Med 1997; 242: 361-5
16. Casey LC, Balk RA, Bone RC. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann Intern Med 1993; 119: 771-8
17. Chachkhiani I, Gurlich R, Maruna P, Frasko R, Lindner J. The post-operative stress response and its reflection in cytokine network and leptin plasma levels. Physiol Res 2005; 54: 279-85
18. Corcoran C, Connor TJ, O'Keane V, Garland MR. The effects of vagus nerve stimulation on pro- and anti-inflammatory cytokines in humans: a preliminary report. Neuroimmunomodulation 2005; 12: 307-9
19. Cowan MJ, Kogan H, Burr R, Hendershot S, Buchanan L. Power spectral analysis of heart rate variability after biofeedback training. J Electrocardiol 1990; 23: 85-94
20. Czura CJ, Tracey KJ. Autonomic neural regulation of immunity. J Intern Med 2005; 257: 156-66
21. Damas P, Canivet J, De Groote D, et al. Sepsis and serum cytokine concentrations. Crit Care Med 1997; 25: 405-12
22. Date Y, Murakami N, Toshinai K, et al. The role of the gastric afferent vagal nerve in ghrelin-induced feeding and growth hormone secretion in rats. Gastroenterology 2002; 123: 1120-8
23. Delves PJ, Roitt IM. The immune system: first of two parts. N Engl J Med 2000; 343: 37-49
24. Dias Da Silva VJ, Gnecchi-Ruscone T, Lavelli B, et al. Opposite effects of iv amiodarone on cardiovascular vagal and sympathetic efferent activities in rats. Am J Physiol 2002; 283: R543-8
25. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991; 77: 1627-52
26. Ek M, Kurosawa M, Lundeberg T, Ericsson A. Activation of vagal afferents after intravenous injection of interleukin-1β: role of endogenous prostaglandins. J Neurosci 1998; 18: 9471-9
27. Esmon CT. Possible involvement of cytokines in diffuse intravascular coagulation and thrombosis. Baillieres Clin Haem 1994; 7: 453-66
28. Fisher CJ, Dhainaut JA, Opal SM, et al. Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome: results from a randomized, double-blind, placebo-controlled trial. J Am Med Assoc 1994; 271: 1836-43
29. Gallowitsch-Puerta M, Pavlov VA. Neuro-immune interactions via the cholinergic anti-inflammatory pathway. Life Sci 2007; 80: 2325-9
30. Goehler LE, Relton JK, Dripps D, et al. Vagal paraganglia bind interleukin-1 receptor antagonist: a possible mechanism for immune-to-brain communication. Brain Res Bull 1997; 43: 357-64
31. Guarini S, Altavilla D, Cainazzo M, et al. Efferent vagal fibre stimulation blunts nuclear factor κB activation and protects against hypovolemic hemorrhagic shock. Circulation 2003; 107: 1189-94
32. Guarini S, Cainazzo M, Giuliani D, et al. Adrenocorticotropin reverses hemorrhagic shock in anesthetized rats through rapid activation of a vagal anti-inflammatory pathway. Cardiovasc Res 2004; 63: 357-65
33. Gutierrez EG, Banks WA, Kastin AJ. Murine tumor necrosis factor alpha is transported from blood to brain in the mouse. J Neuroimmunol 1993; 47: 169-76
34. Haker E, Egekvist H, Bjerring P. Effect of sensory stimulation (acupuncture) on sympathetic and parasympathetic activities in healthy subjects. J Auton Nerv Syst 2000; 79: 52-9
35. Hoch RC, Rodriguez R, Manning T, et al. Effects of accidental trauma on cytokine and endotoxin production. Crit Care Med 1993; 21: 839-45
36. Huang ST, Chen GY, Lo HM, Lin JG, Lee YS, Kuo CD. Increase in the vagal modulation by acupuncture at neiguan point in healthy subjects. Am J Chin Med 2005; 1: 157-64
37. Huston JM, Gallowitsch-Puerta M, Ochani M, et al. Transcutaneous vagus nerve stimulation reduces high mobility group box 1 levels and improves survival in murine sepsis. Crit Care Med 2007; 35: 2762-8
38. Huston JM, Ochani M, Rosas-Ballina M, et al. Splenectomy inactivates the cholinergic anti-inflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med 2006; 203: 1623-8
39. Jiang JX, Tian KL, Chen HS, Zhu PF, Wang ZG. Plasma cytokines and endotoxin levels in patients with severe injury and their relationship with organ damage. Injury 1997; 28: 509-13
40. Kato M, Suzuki H, Murakami M, Akama M, Matsukawa S, Hashimoto Y. Elevated plasma levels of interleukin-6, interleukin-8, and granulocyte colony-stimulating factor during and after major surgery. J Clin Anesth 1997; 9: 293-8
41. Kelly RA, Smith TW. Cytokines and cardiac contractile function. Circulation 1997; 95: 778-81
42. Kitagawa H, Tekenouchi T, Azuma R, et al. Safety, pharmacokinetics and effects of cognitive function of multiple doses of GTS-21 in healthy male volunteers. Neuropsychopharmacology 2003; 28: 542-51
43. Kox M, Pompe JC, Pickkers P, Hoedemaekers CW, van Vugt AB, van der Hoeven JG. Increased vagal tone accounts for the observed immune paralysis in patients with traumatic brain injury. Neurology 2008; 70: 480-5
44. Kubota Y, Sato W, Toichi M, et al. Frontal midline theta rhythm is correlated with cardiac autonomic activities during performance of an attention demanding meditation procedure. Cogn Brain Res 2001; 11: 281-7
45. Kudoh A, Katagai H, Takazawa T, Matsuki A. Plasma proinflammatory cytokine response to surgical stress in elderly patients. Cytokine 2001; 15: 270-3
46. Lantz M, Gullberg U, Nilsson E, Olsson I. Characterization in vitro of a human tumor necrosis factor-binding protein. A soluble form of a tumor necrosis factor receptor. J Clin Invest 1990; 86: 1396-402
47. Lee AH, Afessa B. The association of nicotine replacement therapy with mortality in a medical intensive care unit. Crit Care Med 2007; 35: 1517-21
48. Le Tulzo Y, Shenkar R, Kaneko D, et al. Hemorrhage increases cytokine expression in lung mononuclear cells in mice: involvement of catecholamines in nuclear factor-kappa B regulation and cytokine expression. J Clin Invest 1997; 99: 1516-24
49. Lin E, Calvano SE, Lowry SF. Inflammatory cytokines and cell response in surgery. Surgery 2000; 127: 117-6
50. Martin TE. Lung cytokines and ARDS: Roger S. Mitchell lecture. Chest 1999; 116: 2S-8S
51. McBride WT, Armstrong MA, McBride SJ. Immunomodulation: an important concept in modern anaesthesia. Anaesthesia 1996; 51: 465-73
52. Mioni C, Bazzani C, Giuliani D, et al. Activation of an efferent cholinergic pathway produces strong protection against myocardial ischemia/reperfusion injury in rats. Crit Care Med 2005; 33: 2621-8
53. Mukaida N, Harada A, Matsushima K. Interleukin-8 (IL-8) and monocyte chemotactic and activating factor (MCAF/MCP-1), chemokines essentially involved in inflammatory and immune reactions. Cytokine Growth Factor Rev 1998; 9: 9-23
54. Nishijo K, Mori H, Yosikawa K, Yazawa K. Decreased heart rate by acupuncture stimulation in humans via facilitation of cardiac vagal activity and suppression of cardiac sympathetic nerve. Neurosci Lett 1997; 227: 165-8
55. Nolan RP, Kamath MV, Floras JS, et al. Heart rate variability biofeedback as a behavioral neurocardiac intervention to enhance vagal heart rate control. Am Heart J 2005; 149: 1137
56. Oral H, Dorn GW, Mann DL. Sphingosine mediates the immediate negative inotropic effects of tumor necrosis factor-α in the adult mammalian cardiac myocyte. J Biol Chem 1997; 272: 4836-42
57. Pagani FD, Baker LS, His C, Knox M, Fink MP, Visner MS. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-α in conscious dogs. J Clin Invest 1992; 90: 389-98
58. Paul-Labrador M, Polk D, Dwyer JH, et al. Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease. Arch Intern Med 2006; 166: 1218-24
59. Pavlov VA, Ochani M, Gallowitsch-Puerta M, et al. Central muscarinic cholinergic regulation of the systemic inflammatory response during endotoxemia. Proc Natl Acad Sci USA 2006; 103: 5219-23
60. Pavlov VA, Ochani M, Yang LH, et al. Selective α7-nicotinic acetylcholine receptor agonist GTS-21 improves survival in murine endotoxemia and severe sepsis. Crit Care Med 2007; 35: 1139-44
61. Pavlov VA, Tracey KJ. The cholinergic anti-inflammatory pathway. Brain Behav Immun 2005; 19: 493-9
62. Pavlov VA, Tracey KJ. Controlling inflammation: the cholinergic anti-inflammatory pathway. Biochem Soc Trans 2006; 34: 1037-40
63. Pawelec G, Adibzadeh M, Pohla H, Schaudt K. Immunosenescence: ageing of the immune system. Immunol Today 1995; 16: 420-2
64. Peng CK, Henry IC, Mietus JE, et al. Heart rate dynamics during three forms of meditation. Int J Cardiol 2004; 95: 19-27
65. Plotkin SR, Banks WA, Kastin AJ. Comparison of saturable transport and extracellular pathways in the passage of interleukin-1α across the blood - brain barrier. J Neuroimmunol 1996; 67: 41-7
66. Saeed RW, Varma S, Peng-Nemeroff T, et al. Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med 2005; 201: 1113-23
67. Sakakibara M, Takeunchi S, Hayano J. Effect of relaxation training on cardiac parasympathetic tone. Psychophysiology 1994; 31: 223-8
68. Salo M. Cytokines and attenuation of responses to surgery. Acta Anaesthesiol Scand 1996; 40: 141-2
69. Schachter SC. Vagus nerve stimulation: where are we? Curr Opin Neurol 2002; 15: 201-6
70. Schachter SC. Vagus nerve stimulation therapy summary. Five years after FDA approval. Neurology 2002; 59: S15-20
71. Schafer M, Carter L, Stein C. Interleukin 1β and corticotrophin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc Natl Acad Sci USA 1994; 91: 4219-23
72. Sheeran P, Hall GM. Cytokines in anaesthesia. Br J Anaesth 1997; 78: 201-19
73. Shenkar R, Coulson WF, Abraham E. Hemorrhage and resuscitation induce alterations in cytokine expression and the development of acute lung injury. Am J Respir Cell Mol Biol 1994; 10: 290-7
74. Sierpina VS, Frenkel MA. Acupuncture: a clinical review. South Med J 2005; 98: 330-7
75. Terathongkum S, Pickler RH. Relationships among heart rate variability, hypertension and relaxation techniques. J Vasc Nurs 2004; 22: 78-82
76. Tracey KJ. The inflammatory reflex. Nature 2002; 420: 853-9
77. Tracey KJ. Physiology and immunology of the cholinergic anti-inflammatory pathway. J Clin Invest 2007; 117: 289-96
78. Tracey KJ, Fong Y, Hesse DG, et al. Anti-cachetin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 1987; 330: 662-4
79. van der Poll T, Coyle SM, Barbosa K, Braxton CC, Lowry SF. Epinephrine inhibits tumor necrosis factor-α and potentiates interleukin 10 production during human endotoxemia. J Clin Invest 1996; 97: 713-9
80. van Dixhoorn J, White A. Relaxation therapy for rehabilitation and prevention in ischaemic heart disease: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil 2005; 12: 193-202
81. van Westerloo DJ, Giebelen IAJ, Florquin S, et al. The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J Infect Dis 2005; 191: 2138-48
82. van Westerloo DJ, Giebelen IAJ, Meijers JCM, et al. Vagus nerve stimulation inhibits activation of coagulation and fibrinolysis during endotoxemia in rats. J Thromb Haemost 2006; 4: 1997-2002
83. Wakefield CH, Barclay GR, Fearon KCH, et al. Proinflammatory mediator activity, endogenous antagonists and the systemic inflammatory response in intra-abdominal sepsis. Br J Surg 1998; 85: 818-25
84. Wang H, Liao H, Ochani M, et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 2004; 10: 1216-21
85. Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature 2003; 421: 384-8
86. Watkins LR, Goehler LE, Relton JK, et al. Blockade of interleukin-1 induced hyperthermia by subdiaphragmatic vagotomy: evidence for vagal mediation of immune-brain communication. Neurosci Lett 1995; 183: 27-31
87. Watkins LR, Maier SF, Goehler LE. Cytokine-to-brain communication: a review and analysis of alternative mechanisms. Life Sci 1995; 57: 1011-26
88. Wu R, Dong W, Cui X, et al. Ghrelin down-regulates proinflammatory cytokines in sepsis through activation of the vagus nerve. Ann Surg 2007; 245: 480-6
89. Wu R, Zhou M, Cui X, Simms H, Wang P. Upregulation of cardiovascular ghrelin receptor occurs in the hyperdynamic phase of sepsis. Am J Physiol 2004; 287: H1296-302